Label Copy Sample Clauses

Label Copy. Newco shall provide all labeling, product inserts and packaging for the Antibodies provided that Baxter has reviewed and -------- approved in writing each use or display on such labels, inserts or packaging of any trademark, trade name, service xxxx or logo used or owned by Baxter, other than any trademark, trade name, service xxxx or logo licensed to Baxter pursuant to Section 6.1 of this Agreement. If a trademark, trade name, service xxxx or logo owned or used by Baxter or its parent corporation, other than any trademark, trade name, service xxxx or logo licensed to Baxter pursuant to Section 6.1 of this Agreement, is to be used in connection with the Antibodies (except to the extent such use is mandatory in connection with the labeling requirements of applicable law) Newco shall obtain prior written authorization from Baxter (which authorization may be withheld by Baxter in its sole discretion) for such use and for all subsequent changes to the art work, labels, inserts or packaging for the Antibodies that incorporate such a Baxter trademark, trade name, service xxxx or logo. Each use of such a Baxter trademark, trade name, service xxxx or logo shall inure to the benefit of Baxter and its parent company. Should any such use vest in Newco any rights in a trademark, trade name, service xxxx or logo used by Baxter, other than any trademark, trade name, service xxxx or logo licensed to Baxter pursuant to Section 6.1 of this Agreement, Newco shall transfer such rights to Baxter or its designee upon the request of Baxter. Except as provided in this Agreement, Newco shall not use any trademark, trade name, service xxxx or logo claimed by Baxter or any confusingly similar trademark, trade name, service xxxx or logo during or after the Term of this Agreement.
AutoNDA by SimpleDocs
Label Copy. All label copy and changes therein, on the Product label itself and other label copy that Cadence uses to market Product in the Territory, will be the responsibility of Cadence. Any Product label affixed by Baxter to a Product shall be in the form most recently approved by Cadence.
Label Copy. Baxter shall provide all specifications for labeling, ---------- product inserts and packaging for the Supplied Products. If Nexell requests changes in the Supplied Product labeling and Baxter agrees to make such changes, such changes in the Supplied Product labeling and the cost of labeling made obsolete by such changes will be paid for by Nexell at Xxxxxx'x Fully Loaded Cost.
Label Copy. The parties acknowledge and agree that Nexell has provided all specifications for labeling, product inserts and packaging for the Products covered under the Regulatory Files prior to the Effective Date.
Label Copy. Xxxxxx covenants and agrees that as of the date that is one (1) year after the date hereof, no label, insert, advertising, packaging or marketing materials used in connection with any product of Xxxxxx or any Affiliate of Xxxxxx that is the same or similar to a Supplied Product and that is produced, manufactured, marketed, sold or distributed by Xxxxxx or any Affiliate of Xxxxxx for uses other than uses which would violate Section 2.1 of this Agreement will refer to uses which would violate Section 2.1 of this Agreement or describe such product as used or usable for uses which would violate Section 2.1 of this Agreement.
Label Copy. All label copy and changes thereto on the Product label shall be the responsibility of Cadence, and LL shall affix to the Product labels in the form most recently approved by Cadence.
Label Copy. All label copy and changes thereto on the Product label shall be the responsibility of Cadence, and LL shall affix to the Product labels in the form most recently approved by Cadence. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
AutoNDA by SimpleDocs
Label Copy. 2.10 Samples as required by the country For a product that has an existing product registration approval issued by any ASEAN member country, the following shall be submitted to the cosmetic regulatory agency in the other country/ies where the product is to be marketed: Notification Letter advising the cosmetic regulatory agency that the product will be marketed in the country. The Notification shall consist the following information: Name of Product Product Brand Product Description (Describe the form of cosmetics such as cream, gel, powder, pencil, stick etc.) Purpose of Cosmetic (intended use) (Describe the purpose of the cosmetic such as baby product, deodorant, eye lotion, hair dye, hair shampoo, skin moisturizer, etc.) Product Formula (Shall consist of full ingredients listing and indicate percentage of restricted ingredients) Packaging particulars (Describe the packaging and their pack sizes, e.g. glass, 10ml, 30ml & 100ml) Name and address of person responsible for putting the product on the market Name and address of manufacturer or contract manufacturer Name and address of importer A copy of the product label Certificate of Product Registration certified true copy by the issuing agency. Appendix V: Common Requirements for Import/Export of ASEAN Cosmetic Products Scope Only regulatory requirements imposed by health authorities are considered in this document. The requirements are applicable to Phase I of the harmonised scheme only. Import Requirements Registration of registrants or companies/persons responsible for placing the product in the market This will facilitate investigations and follow up by regulatory authorities in the event of product problems. Registration of registrant or company/person responsible for placing the product in the market should be based on the requirements of individual countries. Product Registration Only countries which wish to register cosmetic products will be involved. The requirements in the approved Technical Document on Product Registration procedures should be followed.

Related to Label Copy

  • EXECUTED COPY Any fully executed photocopy or similar reproduction of this Lease shall be deemed an original for all purposes.

  • EXECUTION COPY Total Debt to Consolidated Total EBITDA Ratio as at the end of such fiscal year or period, as the case may be for the purpose of determining the Commitment Fee payable pursuant to Section 4.1(a); (iii) a specification of any change in the identity of the Restricted Subsidiaries, the Unrestricted Subsidiaries, the Specified Subsidiaries, the Immaterial Subsidiaries and the Foreign Subsidiaries as at the end of such fiscal year or period, as the case may be, from the Restricted Subsidiaries, the Unrestricted Subsidiaries, the Specified Subsidiaries, the Immaterial Subsidiaries and the Foreign Subsidiaries, respectively, provided to the Lenders on the Closing Date or the most recent fiscal year or period, as the case may be, (iv) the then applicable pricing level, (v) the calculations and basis, in reasonable detail, of any “run rate” cost savings added back to Consolidated EBITDA pursuant to the provisions of clause (a)(xi) of the definition thereof and (vi) the amount of any Pro Forma Adjustment not previously set forth in a Pro Forma Adjustment Certificate or any change in the amount of a Pro Forma Adjustment set forth in any Pro Forma Adjustment Certificate previously provided and, in either case in reasonable detail, the calculations and basis therefor. At the time of the delivery of the financial statements provided for in Section 9.1(a), a certificate of an Authorized Officer of the Borrower setting forth (i) in reasonable detail the calculation of the Available Amount and the Available Equity Amount as at the end of the fiscal year to which such financial statements relate and (ii) the information required pursuant to Section 2 of the Perfection Certificate or confirming that there has been no change in such information since the Closing Date or the date of the most recent certificate delivered pursuant to this Section 9.1(d), as the case may be.

  • Purpose and Application This document (“DPA”) is incorporated into the Agreement and forms part of a written (including in electronic form) contract between SAP and Customer. This DPA applies to Personal Data processed by SAP and its Subprocessors in connection with its provision of the Cloud Service. This DPA does not apply to non-production environments of the Cloud Service if such environments are made available by SAP, and Customer shall not store Personal Data in such environments.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Format The data will be provided in the format specified in Specification 2 for Data Escrow (including encryption, signing, etc.) but including only the fields mentioned in the previous section, i.e., the file will only contain Domain and Registrar objects with the fields mentioned above. Registry Operator has the option to provide a full deposit file instead as specified in Specification 2.

  • Complete Copies of Materials The Company has delivered or made available true and complete copies of each document (or summaries of same) that has been requested by Parent or its counsel.

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Receipt of Copy Mortgagor acknowledges that it has received a true copy of this Mortgage.

  • Research Records Each Party shall maintain records of each Research Program (or cause such records to be maintained) in sufficient detail and in good scientific manner as will properly reflect all work done and results achieved by or on behalf of such Party in the performance of such Research Program. All laboratory notebooks shall be maintained for no less than the term of any Patent issuing therefrom. All other records shall be maintained by each Party during the relevant Research Term and for [**] thereafter. All such records of a Party shall be considered such Party’s Confidential Information.

Time is Money Join Law Insider Premium to draft better contracts faster.